PediaLean Letter Signals Widening Commerce Cmte. Supplement Probe
This article was originally published in The Tan Sheet
Executive Summary
The House Energy & Commerce Committee has expanded its investigation of the dietary supplement industry with a letter to the manufacturer of the PediaLean pediatric weight-loss supplement
You may also be interested in...
FDA Delays Implementation Of Radiofrequency Identification Standards
FDA for the third time extended a compliance policy guide for radiofrequency identification tagging of pharmaceuticals in a bid for more time to implement legislation for ensuring quality control.
Pediatric Supplement Hearing Planned In House; Durbin Slams DSHEA
The House Energy & Commerce/Oversight & Investigations subcommittee is planning a hearing on dietary supplements for obesity in children June 16
Energy & Commerce wants the skinny
Subpoena for previously requested information from Skinny Pill for Kids marketer Edita Kaye authorized June 12 by House Energy & Commerce/Subcommittee on Oversight & Investigations. Rep. James Greenwood (R-Penn.) stated Kaye and her counsel "have not provided any responsive documents or narrative responses," instead claiming that because the product was never distributed, she is not obligated to reply. Kaye made similar defense to a NAD inquiry (1"The Tan Sheet" March 31, 2003 In Brief). Committee expanded supplement probe focus beyond ephedra to include pediatric products with March 25 letter to PediaLean manufacturer (2"The Tan Sheet" April 14, 2003, p. 3)...